![]() |
市场调查报告书
商品编码
1494466
北美助听器市场预测至 2030 年 - 区域分析 - 按类型、产品类型、技术、听力损失类型、患者类型和配销通路North America Hearing Aids Market Forecast to 2030 - Regional Analysis - by Type, Product Type, Technology, Type Of Hearing Loss, Patient Type, and Distribution Channel |
2022年北美助听器市值为102.2281亿美元,预计2030年将达到154.5297亿美元;预计2022年至2030年复合年增长率为5.3%。
听力损失发生率上升推动北美助听器市场
听力损失深刻影响人类经验的各个层面,包括身体、情绪和心理健康。老年人口的增加导致听力损失人数不断增加,因为这个年龄层的听力损失风险较高。根据世界卫生组织 (WHO) 统计,到 2020 年,全球 60 岁以上人口将接近 10 亿,预计到 2030 年底将达到 14 亿,到 2050 年将达到 21 亿。人口(4.32 亿人)将需要復健治疗来解决听力损失问题,预计到2050 年底这一数字将超过7 亿。暴露在过度噪音中是数百万美国年轻人和老年人听力损失的主要原因之一。短期和重复的噪音暴露都会对内耳造成持久损害,导致永久性听力损失。对于在噪音环境中工作的人来说,这是一个特别的风险。根据美国听力损失协会 (HLAA) 的《听力损失事实与统计》,每年约有 2,200 万名美国工人在工作场所暴露在危险的噪音水平下。同一消息来源进一步指出,该国五分之一的男性和八分之一的女性报告有听力问题。如果不及时治疗,听力损失会随着时间的推移而恶化。助听器可以透过提供可能因听力损失而流失或减少的听觉刺激来显着改善个人的生活品质。因此,听力损失盛行率的上升,无论是全部还是部分,是推动人们对助听器设备需求的关键因素,从而推动助听器市场的成长。
北美助听器市场概况
根据美国国家耳聋和其他沟通障碍研究所的数据,到2021 年,约3,000 万人(占12 岁及以上美国人口的13%)出现单耳或双耳听力损失。患有听力损失。该国拥有全球领先的市场参与者,专注于产品开发和发布。此外,FDA 对 OTC 助听器的批准预计将在市场上创造充足的机会。 2023 年 10 月,Audien Hearing 推出了世界上第一款符合 FDA 标准的非处方 (OTC) 助听器——ATOM ONE,售价不到 100 美元。购买适合他们或他们所爱之人需求的经济型设备。 2023年10月,人工智慧助听器和音讯解决方案供应商ELEHEAR推出了首款OTC助听设备-ELEHEAR Alpha和ELEHEAR Alpha Pro。因此,大量人群中听力障碍的盛行率不断上升、新产品的推出以及以经济的价格提供非处方助听器有利于美国市场的成长。
北美助听器市场收入及 2030 年预测(百万美元)
北美助听器市场细分
北美助听器市场根据类型、产品类型、技术、听力损失类型、患者类型、配销通路和国家进行细分。根据类型,北美助听器市场分为处方助听器和非处方助听器。处方助听器细分市场到 2022 年将占据更大的市场。
从产品类型来看,北美助听器市场分为助听器和听力植入物。到 2022 年,助听设备细分市场将占据更大的市场份额。 (RITE)助听器、耳道助听器等。此外,听力植入物部分分为耳蜗植入物和骨传导植入物。
依技术划分,北美助听器市场分为传统助听器和数位助听器。到 2022 年,传统助听器细分市场将占据更大的市场份额。
根据听力损失的类型,北美助听器市场分为感音神经性听力损失和传导性听力损失。 2022 年,感音神经性听损细分市场将占据更大的市场。
根据患者类型,北美助听器市场分为成人和儿童。 2022 年,成人细分市场占据更大的市场份额。
根据配销通路,北美助听器市场分为药局、零售店和网路。 2022 年,药局领域占据最大的市场份额。
根据国家/地区,北美助听器市场分为美国、加拿大和墨西哥。 2022年,美国在北美助听器市场份额中占据主导地位。
Starkey Laboratories Inc.、Audina Hearing Instruments Inc.、Sebotek Hearing Systems LLC、Earlens Corp、GN Store Nord AS、Cochlear Ltd、WS Audiology AS、Sonova Holding AG、Sonic Innovations Inc 和 Amplifon Hearing Health Care Corp. 是一些领先的公司在北美助听器市场营运的公司。
The North America hearing aids market was valued at US$ 10,222.81 million in 2022 and is expected to reach US$ 15,452.97 million by 2030; it is estimated to register a CAGR of 5.3% from 2022 to 2030.
Rising Incidence of Hearing Loss Fuels North America Hearing Aids Market
Hearing loss profoundly impacts every dimension of the human experience, including physical, emotional, and mental health. The rising geriatric population contributes to the growing number of people with hearing loss, as the risk of hearing loss is higher in this age group. According to the World Health Organization (WHO), there were nearly 1 billion people in 2020 aged 60 years and above globally, which is expected to reach 1.4 billion by the end of 2030 and is projected to reach 2.1 billion by 2050. As per WHO, ~5% of the global population (432 million people) will require rehabilitation to address their hearing loss in 2023, which is expected to reach over 700 million by the end of 2050. Although hearing loss is more common among aged people, people of all ages can be affected. Exposure to excessive noise is one of the leading causes of hearing loss for millions of young and old Americans. Both short-term and repeated noise exposure can cause lasting damage to the inner ear, resulting in permanent hearing loss. It's a particular risk for people working around loud noises. According to the Hearing Loss Association of America (HLAA), Hearing Loss Facts and Statistics, ~22 million US workers are exposed to dangerous noise levels in their workplaces yearly. The same source further stated that one out of five men and one of eight women in the country report hearing trouble. When left untreated, hearing loss can worsen with time. Hearing aids can significantly improve an individual's quality of life by providing auditory stimuli that could have been lost or reduced due to loss of hearing. Thus, the rising prevalence of hearing loss, wholly or partially, is a key factor boosting the demand for hearing aid devices among the population, thereby driving the growth of the hearing aids market.
North America Hearing Aids Market Overview
As per the National Institute on Deafness and Other Communication Disorders, ~30 million people or 13% of the US population aged 12 years and above was experiencing hearing loss in one or both ears in 2021. As per the same source, ~28.8 million people in the US could benefit from the use of hearing aids. Country has presence of the leading global market players, which are focused on product development and launches. Furthermore, FDA approval for OTC hearing aids is expected to create ample opportunities in the market. In October 2023, Audien Hearing launched the world's first FDA-compliant hearing aid sold over-the-counter (OTC)-ATOM ONE-for less than US$ 100. The ATOM ONE would allow millions of people suffering from hearing loss to walk in and purchase an economical device suiting their or their loved ones' needs. In October 2023, ELEHEAR, a provider of AI-powered hearing aids and audio solutions, introduced its first OTC hearing aid devices-the ELEHEAR Alpha and ELEHEAR Alpha Pro. Therefore, increasing prevalence of hearing impairment among large populations, new product launches, and availability of OTC hearing aids at economical pricing favors the market growth in the US.
North America Hearing Aids Market Revenue and Forecast to 2030 (US$ Million)
North America Hearing Aids Market Segmentation
The North America hearing aids market is segmented based on type, product type, technology, type of hearing loss, patient type, distribution channel, and country. Based on type, the North America hearing aids market is bifurcated into prescription hearing aids and OTC hearing aids. The prescription hearing aids segment held a larger market share in 2022.
In terms of product type, the North America hearing aids market is bifurcated into hearing aid devices and hearing implants. The hearing aid devices segment held a larger market share in 2022. Furthermore, the hearing aid devices segment is subsegmented into behind-the-ear (BTE) hearing aid, in-the-ear (ITE) hearing aid, receiver-in-the-ear (RITE) hearing aid, canal hearing aid, and others. Additionally, the hearing implants segment is bifurcated into cochlear implants and bone conduction implants.
By technology, the North America hearing aids market is bifurcated into conventional hearing aids and digital hearing aids. The conventional hearing aids segment held a larger market share in 2022.
Based on type of hearing loss, the North America hearing aids market is bifurcated into sensorineural hearing loss and conductive hearing loss. The sensorineural hearing loss segment held a larger market share in 2022.
Based on patient type, the North America hearing aids market is bifurcated into adults and pediatric. The adults segment held a larger market share in 2022.
Based on distribution channel, the North America hearing aids market is segmented into pharmacies, retail stores, and online. The pharmacies segment held the largest market share in 2022.
Based on country, the North America hearing aids market is segmented into the US, Canada, and Mexico. The US dominated the North America hearing aids market share in 2022.
Starkey Laboratories Inc., Audina Hearing Instruments Inc, Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, and Amplifon Hearing Health Care Corp. are some of the leading companies operating in the North America hearing aids market.